Keppra and Seizures - a phase IV clinical study of FDA data

Summary:

Seizures is found among people who take Keppra, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Keppra and have Seizures. It is created by eHealthMe based on reports of 63,513 people who have side effects when taking Keppra from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Apr, 12, 2023

63,513 people reported to have side effects when taking Keppra.
Among them, 6,563 people (10.33%) have Seizures.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 66,600 Keppra users for its effectiveness, alternative drugs and more.

What is Seizures?

Seizures (abnormal excessive or synchronous neuronal activity in the brain) is found to be associated with 2,816 drugs and 2,131 conditions by eHealthMe.

Number of Keppra and Seizures reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Keppra and have Seizures?

Check whether Seizures is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .

Related studies

How severe was Seizures and when was it recovered:

Seizures in Keppra

Expand to all the drugs that have ingredients of levetiracetam:

Seizures and drugs with ingredients of levetiracetam (11,892 reports)

Alternative drugs to, pros and cons of Keppra:

Keppra (66,600 reports)

Common Keppra side effects:

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6,563 reports
Fatigue (feeling of tiredness): 3,947 reports
Drug ineffective: 3,428 reports
Drowsiness: 2,702 reports
Headache (pain in head): 2,524 reports
Dizziness: 2,508 reports
Weakness: 2,353 reports

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Seizures treatments and more:

Seizures (122,943 reports)

COVID vaccines that are related to Seizures:

Common drugs associated with Seizures:

All the drugs that are associated with Seizures:

Seizures (2,816 drugs)

Common conditions associated with Seizures:

Epilepsy: 9,254 reports
Multiple sclerosis: 6,059 reports
Depression: 2,604 reports
Pain: 2,466 reports
High blood pressure: 1,990 reports

All the conditions that are associated with Seizures:

Seizures (2,131 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levetiracetam (the active ingredients of Keppra) and Keppra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.